Sim · Current issues in molecular biology 2023 · In vitro and in vivo animal laboratory experiment · n=?

The Anti-Inflammatory Effects of Broccoli ( Brassica oleracea L. var. italica) Sprout Extract in RAW 264.7 Macrophages and a Lipopolysaccharide-Induced Liver Injury Model.

Cited 13 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Preclinical in vitro and in vivo animal study without human participants

PubMed 37998749 · doi:10.3390/cimb45110572 · record verified 2026-08-30

What was done

Researchers evaluated the anti-inflammatory effects of a sulforaphane-rich broccoli sprout extract (BSE) using cell and animal models. In vitro, RAW 264.7 macrophages were exposed to lipopolysaccharide (LPS), and inflammatory mediators (COX-2, IL-1β, IL-6, IL-1, iNOS, TNF-α) were assessed via qPCR and enzyme immunoassay. In vivo, mice subjected to LPS-induced endotoxemia and liver injury received BSE pretreatment to measure survival, liver transaminases (ALT, AST), hepatic pro-inflammatory cytokine expression, and macrophage infiltration using F4/80 immunostaining.

What was found

The abstract reports no numerical values or effect sizes. In RAW 264.7 cells, BSE suppressed the expression of COX-2, IL-1β, IL-6, IL-1, iNOS, and TNF-α. In LPS-treated mice, BSE pretreatment improved survival rates, reduced ALT and AST expression, decreased hepatic levels of IL-1β, TNF-α, IL-6, COX-2, and iNOS, and suppressed hepatic F4/80-positive macrophage infiltration.

Why it matters

The findings characterize potential pathways through which broccoli sprout components, particularly sulforaphane, modulate acute inflammatory responses and protect against experimental liver injury.

Limits

The study is restricted to preclinical cell culture and acute mouse models, which may not translate directly to human physiology or clinical inflammatory diseases. The abstract lacks sample sizes, dosing details, and exact quantitative effect estimates with variance metrics.

Cited by